News
Reality: D-SNPs are designed to be affordable for those eligible for both Medicare and Medicaid. In fact, many D-SNPs have low or even no premiums, and they often include reduced out-of-pocket ...
4d
Zacks Investment Research on MSNSynopsys (SNPS) Stock Sinks As Market Gains: What You Should Know
Synopsys (SNPS) closed the most recent trading day at $601.55, moving -1.33% from the previous trading session. This change lagged the S&P 500's daily gain of 0.4%. Meanwhile, the Dow experienced a ...
19d
Zacks Investment Research on MSNSynopsys, Inc. (SNPS) is Attracting Investor Attention: Here is What You Should Know
Synopsys (SNPS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...
13d
Zacks.com on MSNSynopsys (SNPS) Moves 3.6% Higher: Will This Strength Last?
Synopsys (SNPS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
In the preceding three months, 8 analysts have released ratings for Synopsys SNPS +0.81% Get Free Report , presenting a wide array of perspectives from bullish to bearish. The table below offers a ...
Implementing default enrollment into D-SNPs can help to increase enrollment in integrated plans while still allowing flexibility for beneficiaries to consider other alternatives.
Another notable valuation metric for SNPS is its P/B ratio of 7.84. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total ...
This approach was applied to 524 non-coding SNPs found in the Human Gene Mutation Database, which records the results of human disease association studies. The variants mapped to 350 UTRs, and 206 ...
The number of I-SNPs operating in the US grew from 35 in 2006 to 174 in 2021. Also during that span, the share of long-stay nursing home residents in I-SNPs jumped from 2.2% to 8.8% of all long ...
The usability of SNPs portend a robust market for instrumentation, reagents, software, and services. SNP analysis revenues are estimated to exceed $625 million in 2007 and grow to over $2.2 ...
SNPS currently has a forward P/E ratio of 32.48, while CDNS has a forward P/E of 36.56. We also note that SNPS has a PEG ratio of 2.01. This popular metric is similar to the widely-known P/E ratio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results